• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Viruses . An Epidemiological Analysis of SARS-CoV-2 Genomic Sequences from Different Regions of India

tetano

Editor, Senior Moderator
Viruses


. 2021 May 17;13(5):925.
doi: 10.3390/v13050925.
An Epidemiological Analysis of SARS-CoV-2 Genomic Sequences from Different Regions of India


Pragya D Yadav[SUP] 1 [/SUP], Dimpal A Nyayanit[SUP] 1 [/SUP], Triparna Majumdar[SUP] 1 [/SUP], Savita Patil[SUP] 1 [/SUP], Harmanmeet Kaur[SUP] 2 [/SUP], Nivedita Gupta[SUP] 2 [/SUP], Anita M Shete[SUP] 1 [/SUP], Priyanka Pandit[SUP] 1 [/SUP], Abhinendra Kumar[SUP] 1 [/SUP], Neeraj Aggarwal[SUP] 2 [/SUP], Jitendra Narayan[SUP] 2 [/SUP], Neetu Vijay[SUP] 2 [/SUP], Usha Kalawat[SUP] 3 [/SUP], Attayur P Sugunan[SUP] 4 [/SUP], Ashok Munivenkatappa[SUP] 5 [/SUP], Tara Sharma[SUP] 6 [/SUP], Sulochna Devi[SUP] 7 [/SUP], Tapan Majumdar[SUP] 8 [/SUP], Subhash Jaryal[SUP] 9 [/SUP], Rupinder Bakshi[SUP] 10 [/SUP], Yash Joshi[SUP] 1 [/SUP], Rima Sahay[SUP] 1 [/SUP], Jayanti Shastri[SUP] 11 [/SUP], Mini Singh[SUP] 12 [/SUP], Manoj Kumar[SUP] 13 [/SUP], Vinita Rawat[SUP] 14 [/SUP], Shanta Dutta[SUP] 15 [/SUP], Sarita Yadav[SUP] 16 [/SUP], Kaveri Krishnasamy[SUP] 17 [/SUP], Sharmila Raut[SUP] 18 [/SUP], Debasis Biswas[SUP] 19 [/SUP], Biswajyoti Borkakoty[SUP] 20 [/SUP], Santwana Verma[SUP] 21 [/SUP], Sudha Rani[SUP] 22 [/SUP], Hirawati Deval[SUP] 23 [/SUP], Disha Patel[SUP] 24 [/SUP], Jyotirmayee Turuk[SUP] 25 [/SUP], Bharti Malhotra[SUP] 26 [/SUP], Bashir Fomda[SUP] 27 [/SUP], Vijaylakshmi Nag[SUP] 28 [/SUP], Amita Jain[SUP] 29 [/SUP], Anudita Bhargava[SUP] 30 [/SUP], Varsha Potdar[SUP] 1 [/SUP], Sarah Cherian[SUP] 1 [/SUP], Priya Abraham[SUP] 1 [/SUP], Anjani Gopal[SUP] 31 [/SUP], Samiran Panda[SUP] 2 [/SUP], Balram Bhargava[SUP] 2 [/SUP]



Affiliations
Free article

Abstract

The number of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) cases is increasing in India. This study looks upon the geographic distribution of the virus clades and variants circulating in different parts of India between January and August 2020. The NPS/OPS from representative positive cases from different states and union territories in India were collected every month through the VRDLs in the country and analyzed using next-generation sequencing. Epidemiological analysis of the 689 SARS-CoV-2 clinical samples revealed GH and GR to be the predominant clades circulating in different states in India. The northern part of India largely reported the 'GH' clade, whereas the southern part reported the 'GR', with a few exceptions. These sequences also revealed the presence of single independent mutations-E484Q and N440K-from Maharashtra (first observed in March 2020) and Southern Indian States (first observed in May 2020), respectively. Furthermore, this study indicates that the SARS-CoV-2 variant (VOC, VUI, variant of high consequence and double mutant) was not observed during the early phase of virus transmission (January-August). This increased number of variations observed within a short timeframe across the globe suggests virus evolution, which can be a step towards enhanced host adaptation.

Keywords: India; NGS; SARS-CoV-2; clades; epidemiology.
 
Back
Top Bottom